Insider Trading activities of Aerpio Pharmaceuticals, Inc. (ARPO)

Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Aerpio Pharmaceuticals, Inc. (ARPO) since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Aerpio Pharmaceuticals, Inc. since year 2005. Table 2 shows the detailed insider transactions of Aerpio Pharmaceuticals, Inc. since 2005. The reporting company's ticker symbol is ARPO. The reporting company's CIK number is 1422142.
The total value of stock buying since 2005 is $34,147,238.
The total value of stock sales since 2005 is $1,793,826.
The total value of stock option exercises since 2005 is $0.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Aerpio Pharmaceuticals, Inc. (ARPO).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2019-04 0 $0 1,370,000 $1,402,451 0 $0
2019-03 0 $0 380,446 $370,705 0 $0
2019-01 143,818 $316,609 0 $0 0 $0
2018-12 340,000 $662,579 0 $0 0 $0
2018-11 91,967 $182,673 0 $0 0 $0
2018-08 0 $0 5,300 $20,670 0 $0
2018-06 3,373,182 $12,986,750 0 $0 0 $0
2018-03 18,000 $88,977 0 $0 0 $0
2017-03 3,981,930 $19,909,650 0 $0 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Aerpio Pharmaceuticals, Inc. insiders (ARPO)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2019-04-26 Novartis Ag (10% Owner) Sale 138,704 1.03 142,865
2019-04-25 Novartis Ag (10% Owner) Sale 563,096 1.03 579,988
2019-04-24 Novartis Ag (10% Owner) Sale 16,403 1.03 16,895
2019-04-23 Novartis Ag (10% Owner) Sale 27,554 1.03 28,380
2019-04-22 Novartis Ag (10% Owner) Sale 7,100 .97 6,887
2019-04-15 Novartis Ag (10% Owner) Sale 28,794 .99 28,506
2019-04-12 Novartis Ag (10% Owner) Sale 30,908 1.04 32,144
2019-04-11 Novartis Ag (10% Owner) Sale 57,438 1.08 62,033
2019-04-10 Novartis Ag (10% Owner) Sale 140,230 1.09 152,850
2019-04-09 Novartis Ag (10% Owner) Sale 32,991 1.01 33,320
2019-04-08 Novartis Ag (10% Owner) Sale 27,525 1.02 28,075
2019-04-05 Novartis Ag (10% Owner) Sale 24,661 1.02 25,154
2019-04-04 Novartis Ag (10% Owner) Sale 47,900 1.01 48,379
2019-04-03 Novartis Ag (10% Owner) Sale 58,033 .96 55,711
2019-04-02 Novartis Ag (10% Owner) Sale 51,754 .97 50,201
2019-04-01 Novartis Ag (10% Owner) Sale 116,909 .95 111,063
2019-03-29 Novartis Ag (10% Owner) Sale 63,100 .91 57,421
2019-03-28 Novartis Ag (10% Owner) Sale 88,835 .94 83,504
2019-03-27 Novartis Ag (10% Owner) Sale 50,749 .99 50,241
2019-03-26 Novartis Ag (10% Owner) Sale 177,762 1.01 179,539
2019-01-10 Satter Muneer A (Director) Buy 23,818 2.45 58,449
2019-01-09 Satter Muneer A (Director) Buy 20,000 2.39 47,880
2019-01-08 Satter Muneer A (Director) Buy 20,000 2.20 43,980
2019-01-07 Satter Muneer A (Director) Buy 20,000 2.18 43,560
2019-01-04 Satter Muneer A (Director) Buy 20,000 2.12 42,400
2019-01-03 Satter Muneer A (Director) Buy 20,000 2.08 41,500
2019-01-02 Satter Muneer A (Director) Buy 20,000 1.94 38,840
2018-12-31 Satter Muneer A (Director) Buy 20,000 1.75 34,900
2018-12-28 Satter Muneer A (Director) Buy 20,000 1.72 34,380
2018-12-27 Satter Muneer A (Director) Buy 20,000 1.67 33,420
2018-12-26 Satter Muneer A (Director) Buy 20,000 1.69 33,860
2018-12-21 Satter Muneer A (Director) Buy 20,000 1.84 36,880
2018-12-20 Satter Muneer A (Director) Buy 20,000 1.85 36,980
2018-12-19 Satter Muneer A (Director) Buy 20,000 1.92 38,380
2018-12-18 Satter Muneer A (Director) Buy 20,000 1.99 39,860
2018-12-14 Satter Muneer A (Director) Buy 20,000 2.00 40,100
2018-12-13 Satter Muneer A (Director) Buy 20,000 2.02 40,300
2018-12-12 Satter Muneer A (Director) Buy 20,000 2.05 40,940
2018-12-11 Satter Muneer A (Director) Buy 20,000 2.09 41,840
2018-12-10 Satter Muneer A (Director) Buy 20,000 2.13 42,600
2018-12-07 Satter Muneer A (Director) Buy 20,000 2.14 42,779
2018-12-06 Satter Muneer A (Director) Buy 20,000 2.18 43,580
2018-12-04 Satter Muneer A (Director) Buy 20,000 2.10 42,000
2018-12-03 Satter Muneer A (Director) Buy 20,000 1.99 39,780
2018-11-30 Satter Muneer A (Director) Buy 20,000 1.99 39,700
2018-11-29 Satter Muneer A (Director) Buy 20,000 2.01 40,119
2018-11-28 Satter Muneer A (Director) Buy 20,000 1.94 38,720
2018-11-12 Hoffman Stephen J (Chief Executive Officer) Buy 30,000 2.01 60,299
2018-11-09 Hoffman Stephen J (Chief Executive Officer) Buy 1,967 1.95 3,835
2018-08-20 Novartis Ag (10% Owner) Sale 5,300 3.90 20,670
2018-06-28 Orbimed Capital Gp V Llc Buy 777,500 3.85 2,993,375
2018-06-28 Khuong Chau Quang Buy 777,500 3.85 2,993,375
2018-06-28 Satter Muneer A (Director) Buy 1,818,182 3.85 7,000,000
2018-03-23 Satter Muneer A (Director) Buy 1,000 5.00 5,000
2018-03-21 Satter Muneer A (Director) Buy 4,000 4.85 19,392
2018-03-20 Satter Muneer A (Director) Buy 5,400 4.97 26,859
2018-03-19 Satter Muneer A (Director) Buy 7,600 4.96 37,726
2017-03-15 Gardner Joseph H. (See Remarks) Buy 99,996 5.00 499,980
2017-03-15 Peters Kevin G. (Chief Scientific Officer) Buy 3,642 5.00 18,210
2017-03-15 Khuong Chau Quang (Director) Buy 762,995 5.00 3,814,975
2017-03-15 Castelein Caley (Director) Buy 400,000 5.00 2,000,000
2017-03-15 Satter Muneer A (Director) Buy 1,120,000 5.00 5,600,000
2017-03-15 Weiss Paul M (Director) Buy 272,302 5.00 1,361,510
2017-03-15 Novartis Ag (10% Owner) Buy 560,000 5.00 2,800,000
2017-03-15 Isaly Samuel D (Director) Buy 762,995 5.00 3,814,975

Insider trading activities including stock purchases, stock sales, and option exercises of ARPO listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Aerpio Pharmaceuticals, Inc. (symbol ARPO, CIK number 1422142) see the Securities and Exchange Commission (SEC) website.